Drugs / p28
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01975116 | Aug 2013 → Apr 2015 | anaplastic astrocytoma, anaplastic oligodendroglioma, brainstem neoplasm, choroid plexus neoplasm +5 | Pediatric Brain Tumor Consortium | Completed | No outcome recorded |
| Phase 1 | NCT00914914 | Apr 2009 → Apr 2011 | neoplasm | Dr. Tapas K. Das Gupta | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | p28 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01975116 ↗ |
| Modality | Peptide | “p28, a cancer cell killing peptide.” NCT00914914 ↗ |
| Route | Intravenous | “infused intravenously into the patient over 15-30 minutes.” NCT00914914 ↗ |